"Beyond being a true visionary, Mark has the experience to lead SonaCare both strategically and on a day-to-day basis."

CHARLOTTE, NC. -- SonaCare Medical, LLC, leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that its Board of Directors has appointed Dr. Mark Carol, M.D. as Chief Executive Officer, President and member of the Board effective immediately. In his new role Dr. Carol will take-on expanded responsibilities within the company, including further developing the company's HIFU technology, as well as overseeing commercialization, manufacturing and finance. 

FRIDAY, OCTOBER 3, 2014 CHARLOTTE, NC.  SonaCare Medical, LLC, a leader in minimally invasive high intensity focused ultrasound (HIFU) technology, announced that the Gastroenterology and Urology Device Panel met on Wednesday October 1st with representatives from the FDA and SonaCare Medical to review and vote on recommendations for the interim analysis of SonaCare Medical's Sonablate® 450's safety, efficacy, and risk/benefits ratio for the treatment of biopsy proven recurrent prostate cancer, stage T1c-T2, in patients who have failed primary external beam radiation therapy and have a PSA≤10 ng/mL.

Fast paced sales growth sets a new company record and underscores the continued worldwide acceleration in demand for SonaCare's unique HIFU platform technology

CHARLOTTE, NC -- SonaCare Medical, LLC, the global leader in high intensity focused ultrasound (HIFU), announced record-setting sales of 15 HIFU devices over the past twelve months pointing to a steady worldwide surge in demand for the company's ablation technology. 

SonaCare Medical, LLC, the global leader in urologic high intensity focused ultrasound (HIFU), is proud to provide platinum support for the upcoming 7th International Symposium on Focal Therapy and Imaging in Prostate & Kidney Cancer. This year's symposium takes place at the Langham Huntington Resort in Pasadena, CA from August 21st to 23rd and includes faculty members from seven countries who have put together a comprehensive scientific program including multiple HIFU sessions.

May 27, 2014 CHARLOTTE, NC -- Medical device manufacturer SonaCare Medical reports continuing strong European sales as well as a positive outlook in light of official guideline changes for prostate cancer therapy. The company has further invested in the European market by adding its newest generation high intensity focused ultrasound ("HIFU") equipment to the HIFU center of excellence at University College of London.

Director of Sales added. Commercialization personnel to be placed in targeted metropolitan areas, to bolster company's expanding US equipment sales.

TUESDAY, MAY 13, 2014 CHARLOTTE, NC -- SonaCare Medical, LLC is experiencing significant growth of its FDA cleared Sonatherm® offering with sales to both major academic and luminary sites. To support its accelerating growth, the company has hired Tres Glenn, an experienced urology sales executive, to the newly created position of Director of Sales for the U.S. The impetus for this hire is to further capitalize on the growing demand for the company's new 510K cleared Sonatherm® Laparoscopic Surgical Ablation System. Beginning this summer, the company also plans to add sales and clinical support personnel in several core metropolitan areas to address the increasing demand for its new focused ultrasound offering.

Page 6 of 9

HIFU company


10130 Perimeter Pkwy, Suite 250
      Charlotte, NC 28216

(888) 874-4384


Mon - Fri: 9:00 - 5:00

Latest News

26 September 2017

Medicare recognizes HIFU prostate ablation as a device-intensive procedure driving new ASC payment going into effect on or after October 1, 2017 CHARLOTTE, N.C., Sept. 20, 2017 /PRNewswire/ -- SonaCare...

29 August 2017

CHARLOTTE, N.C., August 30, 2017 – SonaCare Medical, the leading developer and manufacturer of high intensity focused ultrasound (HIFU) technologies, announces today the successful collaboration with BK Ultrasound, achieving compatibility...